Home › Sickle Cell Disease
Pag-aaral pangklinika para sa Sickle Cell Disease na nagre-recruit sa U.S.
106 pag-aaral para sa Sickle Cell Disease ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Washington, DC21 pag-aaral
- Atlanta, GA20 pag-aaral
- Memphis, TN19 pag-aaral
- Chicago, IL18 pag-aaral
- New York City, NY16 pag-aaral
- Philadelphia, PA15 pag-aaral
- Birmingham, AL14 pag-aaral
- Houston, TX12 pag-aaral
- Boston, MA12 pag-aaral
- St. Louis, MO12 pag-aaral
- Durham, NC10 pag-aaral
- Cincinnati, OH10 pag-aaral
- Greenville, NC9 pag-aaral
- Columbus, OH9 pag-aaral
- Pittsburgh, PA9 pag-aaral
- Los Angeles, CA8 pag-aaral
- The Bronx, NY8 pag-aaral
- Baltimore, MD7 pag-aaral
- Charlotte, NC7 pag-aaral
- Cleveland, OH7 pag-aaral
- Oakland, CA7 pag-aaral
- Augusta, GA5 pag-aaral
- Detroit, MI5 pag-aaral
- Hartford, CT5 pag-aaral
- Jackson, MS5 pag-aaral
- Richmond, VA5 pag-aaral
- Phoenix, AZ5 pag-aaral
- Indianapolis, IN5 pag-aaral
- Nashville, TN5 pag-aaral
- Milwaukee, WI4 pag-aaral
- New Orleans, LA4 pag-aaral
- New Haven, CT4 pag-aaral
- Arlington, VA4 pag-aaral
- Greenville, SC4 pag-aaral
- Queens, NY4 pag-aaral
- Minneapolis, MN4 pag-aaral
- Greenburgh, NY3 pag-aaral
- Edison, NJ3 pag-aaral
- Mobile, AL3 pag-aaral
- Rochester, NY3 pag-aaral
Ayos sa estado
- Alabama16 pag-aaral
- Arizona5 pag-aaral
- Arkansas3 pag-aaral
- California19 pag-aaral
- Connecticut7 pag-aaral
- Delaware6 pag-aaral
- District of Columbia11 pag-aaral
- Florida9 pag-aaral
- Georgia23 pag-aaral
- Illinois19 pag-aaral
- Indiana5 pag-aaral
- Louisiana5 pag-aaral
- Maryland17 pag-aaral
- Massachusetts12 pag-aaral
- Michigan9 pag-aaral
- Minnesota6 pag-aaral
- Mississippi5 pag-aaral
- Missouri13 pag-aaral
- New Jersey8 pag-aaral
- New York23 pag-aaral
- North Carolina18 pag-aaral
- Ohio22 pag-aaral
- Pennsylvania20 pag-aaral
- South Carolina6 pag-aaral
- Tennessee22 pag-aaral
- Texas13 pag-aaral
- Virginia8 pag-aaral
- Wisconsin4 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07187973Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07616154A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06439082HPC Offered for PRESERVE Expansion
Nagre-recruitObservasyonal na pag-aaral
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07145411Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
Nagre-recruitPhase 4
Edad 18 hanggang 50 · Kababaihan · Na-update Nob 5, 2026 · NCT06665997Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05904093Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07224360A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07656415A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 12 hanggang 55 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06546670Blood Sampling for Research Related to Sickle Cell Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT00542230AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Nagre-recruitPhase 2
1 Day – 30 Years · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT04099966Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease
Nagre-recruit
Edad 7 hanggang 18 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07090668Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease
Nagre-recruitPhase 1
Edad 13 hanggang 35 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07708350Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT07566494Transplantation of Clustered Regularly Interspaced Short Palindromic Repeats Modified Hematopoietic Progenitor Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease
Nagre-recruitPhase 1/2
Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT04774536Virtual Reality for SCD VOC
Nagre-recruit
Edad 18 hanggang 88 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07674277The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Nagre-recruitPhase 3
Edad 10 hanggang 65 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06975865Gene Editing For Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 hanggang 24 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06506461Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Nagre-recruitPhase 1/2
Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07599176Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
Nagre-recruit
Edad 16 hanggang 39 · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT06374238Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT06699849Exercise in Child Health
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05359991Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03937817A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04055818Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Nagre-recruitMaagang Phase 1
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06313398Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.